期刊文献+

沙棘粗多糖对α-葡萄糖苷酶活性影响及酶动力学的研究 被引量:7

The study on crude polysaccharide of Seabuckthorn against activity of α-glucosidase and its enzyme kinetics
原文传递
导出
摘要 目的:探讨中国沙棘粗多糖中α-葡萄糖苷酶抑制剂的体外酶动力学的特性。方法:利用酶-抑制剂筛选模型,选择沙棘粗多糖,通过改变其浓度、反应时间、pH条件、温度等进行体外酶学动力学研究。结果:沙棘粗多糖浓度在0.0098~0.625 g.L-1之间时,酶的抑制率随着浓度的增大而升高,IC50为0.031 g.L-1;浓度为0.625 g.L-1时抑制率达92.52%,且与酶结合迅速,酸碱范围广,热稳定性好。结论:沙棘粗多糖是一种高活性的竞争可逆性α-葡萄糖苷酶抑制剂,抑制常数Ki=5.26g.L-1。 Objective:To investigate the characteristics of in vitro enzyme kinetics of α - glucosidase inhibitors in crude polysaccharide of Chinese seabuckthorn (Hippophae rhamnoides L. ssp. sinensis Rousi). Method:Highly ac- tive crude polysaccharide of Seabuckthorn was selected by using enzyme - inhibitor screening model, and the in vitro enzyme kinetics was investigated by changing its concentration, reaction time, pH conditions, temperature and oth- ers. Results : When Seabuckthorn polysaccharide concentration is between 0. 0098 g·L^-1 to 0. 625 g·L^-1, the en- zyme inhibitory rate positively correlates with the concentration, IC50 for 0.031 g·L^-1 ; when the concentration rea- ches 0. 625 g·L^-1, and inhibitory rate is up to 92.52% ;Seabuckthorn polysaccharide rapid integrates with the en- zyme, and has wide pH ranged and good thermal stability. Conclusion:Crude polysaccharide of Seabuckthorn is a highly active and competitive reversible inhibitor ofα - glucosidase, with inhibition constant Ki = 5.26 g·L^-1.
出处 《药物分析杂志》 CAS CSCD 北大核心 2012年第12期2154-2157,共4页 Chinese Journal of Pharmaceutical Analysis
基金 青海省自然科学基金项目(2012-Z-909)
关键词 Α-葡萄糖苷酶 抑制剂 沙棘粗多糖 酶-抑制剂筛选模型 酶动力学 α - glucosidase inhibitor crude polysaccharide of Seabuckthorn enzyme - inhibitor screening model enzyme kinetics
  • 相关文献

参考文献14

  • 1陈晓丽,计仁军.糖尿病病因与发病机理[J].中国现代药物应用,2008,2(24):189-190. 被引量:32
  • 2XU Man-yin (许曼音),LU Guang-hua(陆广华),CHEN Ming-dao (陈名道),et al.Diabetes Mellitus(糖尿病学).Shanghai(上海):Shanghai Science and Technology Publishers(上海科学技术出版社),2003.12.
  • 3郭凤霞,曾阳,陈振宁.来源于天然产物的α-葡萄糖苷酶抑制剂筛选研究进展概述[J].青海师范大学学报(自然科学版),2012,28(1):76-80. 被引量:6
  • 4郭风霞,曾阳,徐萌,杨琳.α-葡萄糖苷酶抑制剂的药理研究进展[J].青海师范大学学报(自然科学版),2011,27(1):63-66. 被引量:13
  • 5覃志成,柴可夫.中药治疗糖尿病机制的研究进展[J].浙江中医学院学报,2004,28(1):81-82. 被引量:15
  • 6León D,Crutchlow M,Ham N,et al.Role of glucagon-like peptide-1 in the pathogenesis and treatment of diabetes mellitus.Int J Biochem Cell Biol, 2006,38:845.
  • 7Genugten R,Raalte D,Diamant M.Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide.Diabetes Res Clin Pract,2009,86:26.
  • 8Ye XP,Song CQ,Yuan P,et al.α-glucosidase and α-amylase inhibitory activity of common constituents from traditional Chinese medicine used for diabetes mellitus.Chin J Nat Med,2010,8(5):349.
  • 9LIU Hong-xing (刘红星).The Modern Research into Native Medicinal Materials of Qinghai(青海地道地产药材的现代研究).Xian(西安):Shaanxi Science and Technology Press (陕西科学技术出版社),2007.213.
  • 10赵鑫.沙棘(Sea buckthorn)[J].国外医药(植物药分册),2008,23(1):41-41. 被引量:1

二级参考文献84

共引文献148

同被引文献133

引证文献7

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部